IMI in major scientific journals
Read the full version of IMI Executive Director Michel Goldman’s recent articles in Clinical Pharmacology & Therapeutics and Nature Medicine
ABOUT IMI
The Innovative Medicines Initiative (IMI) is Europe's largest public-private initiative aiming to speed up the development of better and safer medicines for patients.
IMI supports collaborative research projects and builds networks of industrial and academic experts in order to boost pharmaceutical innovation in Europe.
IMI is a joint undertaking between the European Union and the pharmaceutical industry association EFPIA.
STAKEHOLDER FORUM AND 6TH CALL WEBINARS
Webinars on the 6th Call for proposals: 24 & 25 May 2012 Sign up here
Stakeholder Forum on 30 May 2012 in Brussels, with workshops on 6th Call topic on
- antimicrobial resistance
- future topics on vaccines & effectiveness research
PARTNER SEARCH TOOL UPDATED
IMI has updated its Partner Search Tool with the indicative topics European Lead Factory (building a joint European compound library and screening centre) and NewDrugs4BadBugs (antimicrobial resistance).
VISIT IMI'S ONGOING PROJECTS
IMI currently funds 23 projects with a combined budget of over €450 million and covering drug safety and efficacy, knowledge management, and education & training.
EDUCATION & TRAINING
Want to give your career a boost? IMI's Education and Training projects offer information and courses to both students and professionals.
IMI NEWSFLASH 
- 15/05/2012 : IMI’s 6th Call topic webinar on antimicrobial resistance on 24 May & repeated 25 May. Reserve your space & register now:http://t.co/Bn0lFlOD
- 11/05/2012 : Science-Business eXchange cover story: IMI ‘a leader’ in organising precompetitive neuroscience collaborations http://t.co/PCKyBmy1
NEW IMI FUNDING RULES AND SIMPLIFIED PROCEDURES
- See the press release
and factsheet - Read the revised Grant Agreement
Innovative Medicines Initiative 2010